文献速递免疫规划传染病防控与疫情报告

美国12-17岁青少年COVID-19疫苗接种覆盖率(2020年12月14日至2021年7月31日)

COVID-19 Vaccination Coverage Among Adolescents Aged 12-17 Years - United States, December 14, 2020-July 31, 2021.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2021-09-03

CDC利用49个州及DC的疫苗接种数据,评估2020年12月14日至2021年7月31日美国12-17岁青少年COVID-19疫苗接种覆盖率。截至2021年7月31日,至少1剂覆盖率为42.4%,完成2剂系列为31.9%;覆盖率随年龄增长而升高,且各州差异显著。

要点

  • 截至2021年7月31日,12-17岁青少年至少1剂覆盖率为42.4%,完成2剂系列为31.9%。
  • 覆盖率随年龄升高:12-13岁至少1剂36.0%,14-15岁40.9%,16-17岁50.6%。
  • 州间差异大:至少1剂覆盖率从密西西比州20.2%到佛蒙特州70.1%。

核心结论

  • 美国12-17岁青少年COVID-19疫苗接种覆盖率在2021年7月31日仍不理想,至少1剂为42.4%,完成系列为31.9%,且州和年龄组间差异显著。

研究设计与样本

  • CDC利用49个州(除爱达荷州)和DC的疫苗管理数据,评估2020年12月14日至2021年7月31日12-17岁青少年至少1剂和完成2剂系列的覆盖率。

主要发现

  • 截至2021年7月31日,至少1剂覆盖率为42.4%,完成2剂系列为31.9%。
  • 至少1剂覆盖率州范围20.2%(密西西比州)至70.1%(佛蒙特州);完成系列范围10.7%(密西西比州)至60.3%(佛蒙特州)。
  • 12-13、14-15、16-17岁至少1剂覆盖率分别为36.0%、40.9%、50.6%;完成系列分别为25.4%、30.5%、40.3%。

临床怎么用

  • 需提高青少年COVID-19疫苗接种覆盖率并实施预防策略,以降低相关发病和死亡,促进学校安全开放面对面学习。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although severe COVID-19 illness and hospitalization are more common among adults, these outcomes can occur in adolescents (1). Nearly one third of adolescents aged 12-17 years hospitalized with COVID-19 during March 2020-April 2021 required intensive care, and 5% of those hospitalized required endotracheal intubation and mechanical ventilation (2). On December 11, 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine for adolescents aged 16-17 years; on May 10, 2021, the EUA was expanded to include adolescents aged 12-15 years; and on August 23, 2021, FDA granted approval of the vaccine for persons aged ≥16 years. To assess progress in adolescent COVID-19 vaccination in the United States, CDC assessed coverage with ≥1 dose* and completion of the 2-dose vaccination series† among adolescents aged 12-17 years using vaccine administration data for 49 U.S. states (all except Idaho) and the District of Columbia (DC) during December 14, 2020-July 31, 2021. As of July 31, 2021, COVID-19 vaccination coverage among U.S. adolescents aged 12-17 years was 42.4% for ≥1 dose and 31.9% for series completion. Vaccination coverage with ≥1 dose varied by state (range = 20.2% [Mississippi] to 70.1% [Vermont]) and for series completion (range = 10.7% [Mississippi] to 60.3% [Vermont]). By age group, 36.0%, 40.9%, and 50.6% of adolescents aged 12-13, 14-15, and 16-17 years, respectively, received ≥1 dose; 25.4%, 30.5%, and 40.3%, respectively, completed the vaccine series. Improving vaccination coverage and implementing COVID-19 prevention strategies are crucial to reduce COVID-19-associated morbidity and mortality among adolescents and to facilitate safer reopening of schools for in-person learning.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Murthy BP, Zell E, Saelee R, et al. COVID-19 Vaccination Coverage Among Adolescents Aged 12-17 Years - United States, December 14, 2020-July 31, 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34473680. doi:10.15585/mmwr.mm7035e1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。